Holen Sie sich die Stockscreener-App
36.83
2.85%
-1.08
Schlusskurs vom Vortag:
$37.91
Offen:
$36.86
24-Stunden-Volumen:
1.38M
Relative Volume:
0.83
Marktkapitalisierung:
$6.44B
Einnahmen:
$520.18M
Nettoeinkommen (Verlust:
$-348.13M
KGV:
-19.18
EPS:
-1.92
Netto-Cashflow:
$-176.18M
1W Leistung:
+5.23%
1M Leistung:
+18.50%
6M Leistung:
+4.87%
1J Leistung:
-15.66%
1-Tages-Spanne:
$36.32
$37.19
1-Wochen-Bereich:
$34.26
$39.36
52-Wochen-Spanne:
$27.34
$60.87
Legend Biotech Corp Adr Stock (LEGN) Company Profile
Firmenname
Legend Biotech Corp Adr
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie LEGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LEGN
Legend Biotech Corp Adr
|
36.83 | 6.44B | 520.18M | -348.13M | -176.18M | -1.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.45 | 115.69B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
529.24 | 53.25B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
307.99 | 39.22B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
577.89 | 35.78B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
269.63 | 27.68B | 3.81B | -644.79M | -669.77M | -6.24 |
Legend Biotech Corp Adr Stock (LEGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-10-08 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-06-17 | Eingeleitet | Truist | Buy |
| 2024-05-24 | Bestätigt | H.C. Wainwright | Buy |
| 2024-05-23 | Eingeleitet | Deutsche Bank | Buy |
| 2024-04-17 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2024-04-03 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-03-13 | Eingeleitet | Raymond James | Outperform |
| 2023-12-19 | Eingeleitet | Scotiabank | Sector Perform |
| 2023-11-06 | Eingeleitet | Goldman | Buy |
| 2023-05-25 | Eingeleitet | William Blair | Mkt Perform |
| 2023-05-22 | Eingeleitet | Daiwa Securities | Buy |
| 2023-03-29 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-03-24 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-12-06 | Eingeleitet | UBS | Buy |
| 2022-11-02 | Eingeleitet | Evercore ISI | Outperform |
| 2022-11-01 | Eingeleitet | Cowen | Outperform |
| 2022-10-31 | Eingeleitet | Guggenheim | Neutral |
| 2022-06-17 | Eingeleitet | BMO Capital Markets | Outperform |
| 2022-03-15 | Eingeleitet | Barclays | Overweight |
| 2022-01-31 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-01-06 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-21 | Eingeleitet | Piper Sandler | Overweight |
| 2021-05-18 | Eingeleitet | BTIG Research | Buy |
| 2020-07-01 | Eingeleitet | JP Morgan | Overweight |
| 2020-07-01 | Eingeleitet | Jefferies | Buy |
| 2020-06-30 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Legend Biotech Corp Adr Aktie (LEGN) Neueste Nachrichten
Oracle and GameStop Headline Market Cap Stock Movers on Thursday By Investing.com - Investing.com South Africa
Eli Lilly, General Electric among Tuesday’s market cap stock movers By Investing.com - Investing.com India
Eli Lilly, General Electric among Tuesday’s market cap stock movers - Investing.com
CARVYKTI shows lasting impact in multiple myeloma treatment By Investing.com - Investing.com South Africa
RBC Capital maintains outperform rating on Legend Biotech stock By Investing.com - Investing.com South Africa
RBC Capital maintains outperform rating on Legend Biotech stock - Investing.com India
BMO Capital reaffirms outperform rating on Legend Biotech stock By Investing.com - Investing.com South Africa
BMO Capital reaffirms outperform rating on Legend Biotech stock - Investing.com India
Legend Biotech’s SWOT analysis: carvykti drives growth as stock faces competition - Investing.com India
RBC Capital maintains Legend Biotech at outperform with $78 target By Investing.com - Investing.com South Africa
RBC Capital maintains Legend Biotech at outperform with $78 target - Investing.com
AbbVie, Nvidia, and Exelixis Lead Market Cap Stock Movers on Wednesday By Investing.com - Investing.com South Africa
AbbVie, Nvidia, and Exelixis Lead Market Cap Stock Movers on Wednesday - Investing.com
Legend Biotech stock holds $62 target, solid Carvykti sales growth By Investing.com - Investing.com India
Legend Biotech stock holds $62 target, solid Carvykti sales growth - Investing.com
Truist cuts Legend Biotech stock target to $71, maintains buy rating - Investing.com India
Raymond James maintains Legend Biotech Outperform rating - Investing.com
Raymond James maintains Legend Biotech Outperform rating By Investing.com - Investing.com UK
Earnings call transcript: Legend Biotech Q1 2025 sees strong CARVICTI sales boost - Investing.com India
Legend Biotech Q1 2025 slides: CARVYKTI sales surge 135% as path to profitability clarifies - Investing.com India
Legend Biotech Reports First Quarter 2025 Results and Recent Highlights - GlobeNewswire Inc.
Stock Surge: Legend Biotech Corp ADR (LEGN) Closes at 31.37, Marking a -6.08 Increase/Decrease - DWinneX
What Makes Legend Biotech (LEGN) a New Buy Stock - Yahoo Finance
Wall Street Analysts Think Legend Biotech (LEGN) Could Surge 135.16%: Read This Before Placing a Bet - Yahoo Finance
Top investors say Legend Biotech Corp ADR (LEGN) ticks everything they need - Sete News
LEGN stock rated a Buy by Redburn Atlantic - knoxdaily.com
Taking a look at what insiders are doing to gauge the Legend Biotech Corp ADR (LEGN)’s direction - knoxdaily.com
Selling Buzz: Graphjet Technology [GTI] 10% Owner SURIA SUKSES ENGINEERING SDN B sells 2,490,517 shares of the company – Knox Daily - knoxdaily.com
UP Fintech Holding Ltd ADR [TIGR] Records 200-Day SMA of $6.22 - knoxdaily.com
UEC Stock Sees Surge of Approximately 9.34% in Last Five Days - knoxdaily.com
Vir Biotechnology Inc [VIR] Records 200-Day SMA of $8.24 - knoxdaily.com
Arm Holdings plc. ADR [ARM] Officer makes an insider purchase of 9,220 shares worth 1.41 million. - knoxdaily.com
Valero Energy Corp [VLO] Records 200-Day SMA of $134.80 - knoxdaily.com
KE Holdings Inc ADR [BEKE] Records 200-Day SMA of $18.54 - knoxdaily.com
Celestica, Inc [NYSE: CLS] Sees Increase in Stock Value - knoxdaily.com
Perimeter Solutions Inc [PRM] Records 50-Day SMA of $9.97 - knoxdaily.com
JBI Shares Experience Surge in Value - knoxdaily.com
CRGY Shares Experience Surge in Value - knoxdaily.com
Gannett Co Inc [GCI] Records 200-Day SMA of $4.65 - knoxdaily.com
Jamf Holding Corp [JAMF] Shares Rise 5.68 % on Thursday - knoxdaily.com
Mirion Technologies Inc [MIR] Records 200-Day SMA of $13.95 - knoxdaily.com
Vista Energy S.A.B. de C.V ADR [NYSE: VIST] Sees Increase in Stock Value - knoxdaily.com
Ares Management Corp [ARES] stock for 16,977,649 USD was sold by Arougheti Michael J - knoxdaily.com
Banc of California Inc [BANC] Records 50-Day SMA of $13.98 - knoxdaily.com
HSAI Shares Experience Surge in Value - knoxdaily.com
QXO Stock Sees Decline of Approximately -10.59% in Last Five Days - knoxdaily.com
Blue Owl Capital Inc [OWL] Controlled affiliate makes an insider purchase of 1,817,382 shares worth 39.13 million. - knoxdaily.com
Lennar Corp [NYSE: LEN] Sees Increase in Stock Value - knoxdaily.com
Vertiv Holdings Co [NYSE: VRT] Sees Increase in Stock Value - knoxdaily.com
XPeng Inc ADR [XPEV] Records 200-Day SMA of $13.46 - knoxdaily.com
Zurn Elkay Water Solutions Corp [NYSE: ZWS] Sees Increase in Stock Value - knoxdaily.com
Finanzdaten der Legend Biotech Corp Adr-Aktie (LEGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.91%
1.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):